Cargando…
A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma
Targeting the epidermal growth factor receptor (EGFR) is one of the potential ways to treat glioblastoma (GBM). In this study, we investigate the anti-GBM tumor effects of the EGFR inhibitor SMUZ106 in both in vitro and in vivo conditions. The effects of SMUZ106 on the growth and proliferation of GB...
Autores principales: | Jiang, Ying, Huang, Chunhui, Huang, Yaqi, Long, Lifan, Wu, Guowu, Guo, Fengqiu, Huang, Chuan, Liu, Siming, Zhu, Zhengguang, Wu, Shaoyu, Li, Zhonghuang, Zhang, Jiajie, Wan, Shanhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220892/ https://www.ncbi.nlm.nih.gov/pubmed/37242743 http://dx.doi.org/10.3390/pharmaceutics15051501 |
Ejemplares similares
-
Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1(G2032R) and ALK(G1202R)
por: Liu, Siming, et al.
Publicado: (2023) -
Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma
por: Zhang, Lishun, et al.
Publicado: (2021) -
Bisarylureas Based on 1H-Pyrazolo[3,4-d]pyrimidine Scaffold as Novel Pan-RAF Inhibitors with Potent Anti-Proliferative Activities: Structure-Based Design, Synthesis, Biological Evaluation and Molecular Modelling Studies
por: Fu, Yu, et al.
Publicado: (2017) -
Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
por: Tian, Yuanxin, et al.
Publicado: (2011) -
Three Dimensional Quantitative Structure-Activity Relationship of 5H-Pyrido[4,3-b]indol-4-carboxamide JAK2 Inhibitors
por: Wu, Xiaoyun, et al.
Publicado: (2013)